The Effect of Azithromycin in Adults with Stable Neutrophilic COPD: A Double Blind Randomised, Placebo Controlled Trial | PLOS ONE
![What Is the Appropriate Use of Antibiotics In Acute Exacerbations of COPD? - Page 3 of 4 - The Hospitalist What Is the Appropriate Use of Antibiotics In Acute Exacerbations of COPD? - Page 3 of 4 - The Hospitalist](https://www.the-hospitalist.org/wp-content/uploads/legacy/files/images/TH_2012_02_pp18_t01_LG.jpg)
What Is the Appropriate Use of Antibiotics In Acute Exacerbations of COPD? - Page 3 of 4 - The Hospitalist
![Table 2 from Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. | Semantic Scholar Table 2 from Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cff9106b07b1ffd6d0cd98f70fb4829ac1bff4b4/4-Table2-1.png)
Table 2 from Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. | Semantic Scholar
![Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients | Scientific Reports Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep28698/MediaObjects/41598_2016_Article_BFsrep28698_Fig1_HTML.jpg)
Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients | Scientific Reports
![Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease | Thorax Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease | Thorax](https://thorax.bmj.com/content/thoraxjnl/77/11/1079/F1.large.jpg)
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease | Thorax
![PDF] The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial | Semantic Scholar PDF] The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4de5cae4249199ae0afeafee4a7cef12f2198061/3-Table1-1.png)
PDF] The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial | Semantic Scholar
![Biomedicines | Free Full-Text | Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”) Biomedicines | Free Full-Text | Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)](https://www.mdpi.com/biomedicines/biomedicines-11-00740/article_deploy/html/images/biomedicines-11-00740-g001.png)
Biomedicines | Free Full-Text | Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)
![Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/f516168b-ca27-473e-b972-7e038d69ea88/gr1.gif)
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine
![Frontiers | Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations Frontiers | Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations](https://www.frontiersin.org/files/Articles/1229463/fmed-10-1229463-HTML-r2/image_m/fmed-10-1229463-g001.jpg)
Frontiers | Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations
![Safety and efficacy of Azithromycin in prevention of chronic obstructive pulmonary disease exacerbation: systematic review and meta-analysis | Semantic Scholar Safety and efficacy of Azithromycin in prevention of chronic obstructive pulmonary disease exacerbation: systematic review and meta-analysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bca1e16e87c594343d1bb0478f471cf3b4fbdff2/6-Table3-1.png)
Safety and efficacy of Azithromycin in prevention of chronic obstructive pulmonary disease exacerbation: systematic review and meta-analysis | Semantic Scholar
![Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease. - Abstract - Europe PMC Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8686853/bin/JCOPDF-8-450-t002.jpg)
Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease. - Abstract - Europe PMC
![Treatment Failure in COPD Exacerbations Reduced by 3-Month Azithromycin Course - Pulmonology Advisor Treatment Failure in COPD Exacerbations Reduced by 3-Month Azithromycin Course - Pulmonology Advisor](https://www.pulmonologyadvisor.com/wp-content/uploads/sites/21/2019/04/azithromycin_G_458462077.jpg)